Full-Service, Fully Committed
CordenPharma, the global pharmaceutical service & manufacturing platform of International Chemical Investors Group (ICIG), is a full-service Contract Development & Manufacturing Organization (CDMO) for the production of APIs, Drug Products, and associated Packaging Services. Through a growing network of focused investments across Europe and the US organized under Technology Platforms, CordenPharma experts translate complex processes, ideas and projects at any stage of development into high-value products.
CordenPharma’s vertically-integrated supply chain model provides development & manufacturing expertise spanning the complete cGMP supply chain > from regulated raw materials through intermediates, APIs, commercial-scale Drug Product manufacturing, finished dosage formulation, packaging, clinical trial services, & pharma logistics > resulting in reduced development & manufacturing time and cost.
News & Press
- May 28, 2020
COVID-19 > Read CEO Dr. Micheal Quirmbach's Customer Letter Response to COVID-19.
- May 28, 2020
Press Release > CordenPharma & Moderna Extend Strategic Lipid Supply Agreement for Moderna’s Vaccine (mRNA-1273) Against the Novel Coronavirus SARS-CoV-2.
- May 18, 2020
Video > CordenPharma Caponago's Sterile Injectable Drug Product Manufacturing Services
Video > Injectable Manufacturing
COVID-19 TRADE SHOW UPDATE
For CordenPharma's response to COVID-19, please read this letter from CEO Dr. Michael Quirmbach. CONTACT US HERE with any urgent concerns or questions.
Please check our events page for trade show cancellations or rescheduled dates.
Browse our library of Brochures, Product Lists, White Papers, Videos & Webinars.
Place an inquiry here > one of our team of experts will get back to you.